Publications by authors named "Jonathan Berek"

Claim this Profile
C
Cancer in pregnancy: FIGO Best practice advice and narrative review.
Surabhi Nanda, Melanie Nana, Long Nguyen-Hoang, Sumaiya Adam, Fionnuala McAuliffe, Jonathan Berek

Int J Gynaecol Obstet· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer and fertility management: FIGO best practice advice.
Nikhil Purandare, Francisco Ruiloba, Long Nguyen-Hoang, Sarikapan Wilailak, Nozomu Yanaihara, Jonathan Berek

Int J Gynaecol Obstet· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FIGO Cancer Report 2025: Transforming gynecologic oncology through global equity, technological innovation, and preventive strategies.
Sarikapan Wilailak, Jonathan S Berek

Int J Gynaecol Obstet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer of the ovary, fallopian tube, and peritoneum: 2025 update.
Malte Renz, Michael Friedlander, Jonathan S Berek

Int J Gynaecol Obstet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy after cancer: FIGO Best practice advice.
Cynthia Maxwell, Sumaiya Adam, Lina Bergman, Surabhi Nanda, Valerie Tiempo Guinto, Jonathan Berek

Int J Gynaecol Obstet· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Controlled Trial of Impact of Mobile Health Technologies on Human Papillomavirus Vaccination Uptake in Mothers of Vaccine-Eligible Girls in Lagos, Nigeria (mHealth-HPVac).
Kehinde Sharafadeen Okunade, Ayomide I Fayinto, Temitope V Adekanye, Matthew J Allsop, Hameed Adelabu, Jonathan S Berek

JCO Glob Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ENGOT-OV16/NOVA trial of niraparib in recurrent ovarian cancer: Survival and long-term safety.
Ursula A Matulonis, Jørn Herrstedt, Amit Oza, Sven Mahner, Andrés Redondo, Jonathan S Berek

Gynecol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance and accuracy of oncologists' estimates of survival time in recurrent ovarian cancer.
Sharon H Nahm, Belinda E Kiely, Rachel L O'Connell, Yeh Chen Lee, Alison Davis, Jonathan S Berek

Int J Gynecol Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FIGO position statement on opportunistic salpingectomy as an ovarian cancer prevention strategy.
Danielle Mor-Hadar, Sarikapan Wilailak, Jonathan Berek, Orla M McNally,

Int J Gynaecol Obstet· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FIGO 2023 staging for endometrial cancer, when, if it is not now?
Xavier Matias-Guiu, Sigurd Lax, Maria Rosaria Raspollini, Jose Palacios, Wenxin Zheng, Jonathan S Berek

Eur J Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contraceptive strategies for reducing the risk of reproductive cancers.
A R Aliabadi, Sarikapan Wilailak, Orla McNally, Jonathan S Berek, Aparna Sridhar

Int J Gynaecol Obstet· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient care and access to clinical trials in gynaecological oncology: global implications of the early phase of the COVID-19 pandemic.
Sara Nasser, Christina Fotopoulou, Murat Gültekin, Desislava Dimitrova, Esra Bilir, Jonathan Berek

Arch Gynecol Obstet· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Associated Factors of High-Risk Human Papillomavirus Infections among Human Immunodeficiency Virus-Infected Women in Lagos, Nigeria.
Kehinde S Okunade, Kabir B Badmos, Austin Okoro, Nicholas A Awolola, Francisca O Nwaokorie, Jonathan S Berek

Res Sq· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancer.
Felicia Roncolato, Madeleine T King, Rachel L O'Connell, Yeh Chen Lee, Florence Joly, Jonathan S Berek

Gynecol Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classification.
David Mutch, David Gaffney, Xavier Matias-Guiu, Christina Fotopoulou, Nicole Concin, Jonathan S Berek

Int J Gynaecol Obstet· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study.
Vicky Makker, Jose Alejandro Perez-Fidalgo, Giorgio Valabrega, Erika Hamilton, Toon Van Gorp, Jonathan S Berek

Gynecol Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of mobile health technologies on human papillomavirus vaccination uptake among mothers of unvaccinated girls aged 9-14 years in Lagos, Nigeria (mHealth-HPVac): study protocol of a randomised controlled trial.
Kehinde S Okunade, Adebola A Adejimi, Temitope V Adekanye, Matthew J Allsop, Hameed Adelabu, Jonathan S Berek

BMC Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of mobile health technologies on human papillomavirus vaccination uptake among mothers of unvaccinated girls aged 9-14 years in Lagos, Nigeria (mHealth-HPVac): Study protocol of a randomised controlled trial.
Kehinde S Okunade, Adebola A Adejimi, Temitope V Adekanye, Matthew J Allsop, Hameed Adelabu, Jonathan S Berek

Res Sq· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2023 FIGO staging system for endometrial cancer: The evolution of the revolution.
David Gaffney, Xavier Matias-Guiu, David Mutch, Giovanni Scambia, Carien Creutzberg, Jonathan S Berek

Gynecol Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response: FIGO staging of endometrial cancer 2023.
Nicole Concin, Xavier Matias-Guiu, Christina Fotopoulou, Carien Creutzberg, David Mutch, Jonathan S Berek

Int J Gynaecol Obstet· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FIGO statement: Fertility preservation.
Laurie Henry, Jonathan S Berek, Ivonne Diaz, Dov Feldberg, Edgar Mocanu

Int J Gynaecol Obstet· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response: FIGO staging of endometrial cancer: 2023.
Jonathan S Berek, Xavier Matias-Guiu,

Int J Gynaecol Obstet· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix.
William A Peters, P Y Liu, Rolland J Barrett, Richard J Stock, Bradley J Monk, Jonathan S Berek

J Clin Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing cancer mindsets: A randomized controlled feasibility and efficacy trial.
Sean R Zion, Lidia Schapira, Jonathan S Berek, David Spiegel, Carol S Dweck

Psychooncology· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FIGO staging of endometrial cancer: 2023.
Jonathan S Berek, Xavier Matias-Guiu, Carien Creutzberg, Christina Fotopoulou, David Gaffney

J Gynecol Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis